EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy

Bushra Faryal iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, 2025. Verfasst von Bushra Faryal. Beteiligte Einrichtung: Department of Precision Medicine, University of Campania "Luigi Vanvitelli,", Naples, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Autophagy, Epigenesis, Genetic, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer remains one of the most common and lethal malignancies among women. Despite advanced targeted therapies and precision medicine, therapeutic resistance continues to undermine durable clinical responses. Increasing evidence links epigenetic dysregulation and autophagy as central contributors to breast cancer progression, therapy resistance, and metabolic changes. Histone modifications, non‐coding RNAs, and DNA methylation dynamically regulate autophagy‐related genes ( ATGs ), while autophagy itself co‐regulates the epigenetic landscape under chemotherapeutic stress. This two‐way interplay determines tumor cell fate, influencing sensitivity to chemotherapy, endocrine therapy, and targeted agents.

Aims

This article reviews recent studies on epigenetic mechanisms modulating autophagy and their impact on resistance pathways in breast cancer. Furthermore, this article highlighted the emerging role of epigenetic‐autophagy as a biomarker for early detection, disease monitoring, and predicting therapeutic response.

Conclusion

Finally, the review outlined new therapeutic methods that combine epigenetic modulators and autophagy inhibitors with particular attention to AI‐driven drug discovery and precision oncology. Collectively, this review emphasizes the potential of targeting epigenetic–autophagy crosstalk to overcome therapy resistance and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAutophagyEpigenesis, GeneticBiomarkers, TumorHumansPrecision MedicineFemaleDrug Resistance, NeoplasmDNA MethylationGene Expression Regulation, NeoplasticMolecular Targeted TherapyAntineoplastic Agents

Stichwörter der Autor:innen

HDACsautophagybiomarkersbreast cancerdrug discoveryepigeneticstherapy resistance

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli,", Naples, Italy.

ORCID-Profile: Bushra Faryal

Zitieren

APA

Faryal, B. (2025). Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy. Cancer Reports. https://doi.org/10.1002/cnr2.70389

Vancouver

Faryal B. Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy. Cancer Reports. 2025. doi:10.1002/cnr2.70389

BibTeX
@article{Faryal2025,
  author = {Faryal, Bushra},
  title = {Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70389}
}
Kostenlos starten →